Search
for

    Sort by

    Research 121–150 of 1000+

    1. Inhibidor janus kinasa como opción terapéutica en alopecia areata. Reporte de caso 2021
    2. Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature Journal of Dermatological Treatment · 2016 · 40 citations
    3. Alopecia Areata: An Update on Treatment Options for Children Paediatric drugs · 2017 · 21 citations
    4. Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata Journal of the European Academy of Dermatology and Venereology · 2018 · 11 citations
    5. Hair Loss in Lichen Planopilaris and Frontal Fibrosing Alopecia: Not Always Irreversible Skin appendage disorders · 2020 · 9 citations
    6. Efficacy and safety of JAK inhibitors in treating lichen planopilaris or frontal fibrosing alopecia Journal of the European Academy of Dermatology and Venereology · 2025 · 2 citations
    7. Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers Frontiers in Medicine · 2026
    8. Follicular Vitiligo: A Rare and Under Recognized Variant Indian Journal of Dermatology · 2026
    9. Hair today, gone tomorrow Chemistry & Industry · 2016
    10. Resident Memory T Cells in Autoimmune Skin Diseases Frontiers in immunology · 2021 · 50 citations
    11. Drug news and therapeutic news Fundamental & clinical pharmacology · 2023
    12. Small Molecule Inhibitors and Inflammatory Skin Diseases Suez Canal University Medical Journal · 2018
    13. Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo Current dermatology reports · 2017
    14. Use of intramuscular triamcinolone acetonide in intermediate responders to janus kinase inhibition for alopecia areata: Case report Journal of dermatology & dermatologic surgery · 2021
    15. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition Nature medicine · 2014 · 701 citations
    16. Topical tofacitinib for the treatment of alopecia areata affecting facial hair British Journal of Dermatology · 2021 · 7 citations
    17. Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis JAMA Dermatology · 2015 · 41 citations
    18. Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis Journal of the American Academy of Dermatology · 2018 · 49 citations
    19. Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes JAAD Case Reports · 2018 · 24 citations
    20. Topical tofacitinib in treatment of alopecia areata Einstein (São Paulo) · 2020 · 2 citations
    21. Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata JCI insight · 2016 · 196 citations
    22. Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents Journal of Investigative Dermatology Symposium Proceedings · 2017 · 28 citations
    23. Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction Archives of Dermatological Research · 2017 · 27 citations
    24. Remarkable Improvement of Nail Changes in Alopecia Areata Universalis with 10 Months of Treatment with Tofacitinib: A Case Report Case Reports in Dermatology · 2016 · 26 citations
    25. Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose 2021 · 21 citations
    26. Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series Rheumatology and Therapy · 2017 · 16 citations
    27. Role of topical tofacitinib in autoimmune skin disorders: An expert opinion IP Indian Journal of Clinical and Experimental Dermatology · 2024 · 1 citations
    28. Efficacy and safety of tofacitinib in patients with alopecia areata Journal of Pakistan Association of Dermatologists · 2026
    29. Evidence for the off-label use of tofacitinib in alopecia areata Scientific Electronic library online (Sciences Carlos III Health Institute) · 2025
    30. Evaluación de la seguridad de minoxidil oral a dosis bajas en el tratamiento de la alopecia e_Buah · 2024